| AGA | Androgenic Alopecia |
| PRP | Platelet-Rich Plasma |
| PPP | Platelet-poor plasma |
| A-PRP | Autologous-Non-activated Platelet-Rich Plasma |
| AA-PRP | Autologous-Activated Platelet-Rich-Plasma |
| HG | Hair Growth |
| HRG | Hair re-growth |
| GFs | Growth Factors |
| VEGF | Vascular endothelial Growth factors |
| PDGF | Platelet Derived Growth factors |
| IGF-1 | Insulin like Growth factor-1 |
| TGF-ß | TGF-ß: transforming growth factor-beta |
| EGF | Epidermal growth factor |
| PRGF | Plasma rich in growth factor |
| DPCs | Dermal papilla cells |
| DP | Dermal papilla |
| HD | Hair density |
| HC | Hair count |
| HT | Hair thickness |
| H-C | Hair cycle |
| HCS | Hair cross-size |
| EC | European Committee |
| CAT | Committee for Advanced treatments; |
| GMP | Good Manufacturing Practices |
| GCP | Good Clinical Practices |
| GFs | Growth factors |
| HF-MSCs | Human follicle mesenchymal stem cells |
| HFSC | Human follicle stem cells |
| HF-ESCs | Hair Follicle Epithelial Stem Cells |
| KCs | Skin epidermal keratinocytes |
| ECM | Extracellular matrix |
| HF | Hair Follicle |
| HFs | Hair Follicles |
| SVFs | Stromal vascular Fraction Cells |
| AD-MSCs | Adipose-derived Mesenchymal Stem Cells |
| SCs | Stem Cells |
| HLs | Hair Loss |
| HD-AFSCs | Human Intra and Extra Dermal Adipose Tissue-Derived Hair Follicle Stem Cells |
| RPM | Right per minute |
| MPHL | Male pattern hair loss |
| FPHL | Female pattern hair loss |
| ASCs-BT | Adult stem cells based therapy |
| AT | Adipose tissue |
| BM | Bone marrow |
| HA | Hyaluronic acid |
| DHT | Dihydrotestosterone |
| D/P | Dalteparin |
| D/P MPs | Dalteparin and protamine micro-particles |
| AA | Alopecia Areata |
| CaCl-Ca2+ | Calcium chloride |
| PGE2 | Prostaglandin E2 |
| LIF | Leukemia-inhibiting factor |
| EBM | Evidence-based medicine |
| WKS | Weeks |
| MOS | Months. |
| b-FGF | Basic-Fibroblast Growth Factor |
| FGF-7 | Fibroblast Growth Factor-7. |